Skip to main content

Sukhtian Ghiath M.'s Form 4 filing

Outlook Therapeutics, Inc. (OTLK) · filed Jun 1, 2026

Accession no.
0000899140-26-000620
Filed
Jun 1, 2026, 9:30 PM ET
Trade date
May 28, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 6 derivative transactions. Open-market purchases total $5.00M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sukhtian Ghiath M.CIK 0001717441Director, 10% Owner
GMS Ventures & InvestmentsCIK 0001804598Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 28, 2026Common StockPPurchaseAcquired+8,539,709$0.5855+$4,999,999.6222,092,068Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 28, 2026Common StockHLess common codeDisposed−3,458,571––0Indirect
May 28, 2026Common StockPPurchaseAcquired+3,458,571––3,458,571Indirect
May 28, 2026Common StockHLess common codeDisposed−3,458,571––0Indirect
May 28, 2026Common StockPPurchaseAcquired+3,458,571––3,458,571Indirect
May 28, 2026Common StockHLess common codeDisposed−8,571,428––0Indirect
May 28, 2026Common StockPPurchaseAcquired+8,571,428––8,571,428Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)